NEW YORK (GenomeWeb News) - A US Senator last week introduced the first significant piece of legislation addressing pharmacogenomics that if approved into law could have broad implications for the development of molecular diagnostics and targeted therapeutics.
 
Introduced by Illinois Senator Barack Obama last Thursday, the bill, entitled the “Genomics and Personalized Medicine Act of 2006,” would create a new federal agency to oversee personalized medicine.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.